Covid-19 Vaccine Trials India
-
{
- All
- News
-
Bharat Biotech Told To Submit Phase 2 Data Of Its Covid Vaccine Before Starting Phase 3: Report
Bharat Biotech, which had sought Drugs Controller General of India or DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to first submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing some clarifications, before proceeding for the next stage.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
2 Mumbai Hospitals Begin Phase 2, 3 Trials Of Oxford Covishield Vaccine For COVID-19: Report
The civic-run King Edward Memorial (KEM) Hospital in Mumbai today began phase II and III trials of the Oxford Covishield vaccine for COVID-19, an official said.
-
Bharat Biotech Told To Submit Phase 2 Data Of Its Covid Vaccine Before Starting Phase 3: Report
Bharat Biotech, which had sought Drugs Controller General of India or DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to first submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing some clarifications, before proceeding for the next stage.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
2 Mumbai Hospitals Begin Phase 2, 3 Trials Of Oxford Covishield Vaccine For COVID-19: Report
The civic-run King Edward Memorial (KEM) Hospital in Mumbai today began phase II and III trials of the Oxford Covishield vaccine for COVID-19, an official said.
